Apnimed Files for Nasdaq IPO, Targeting Up to $160 Million

Apnimed submitted a filing on Monday for an initial public offering on the Nasdaq exchange, proposing to sell 10 million shares of common stock. The company has set an indicative price range of $14.00 to $16.00 per share, according to the filing.

IPO Details

The planned offering outlines the company's first step toward becoming a publicly-traded entity. Upon successful listing, Apnimed intends to trade under the ticker symbol APMD.

Key terms of the proposed IPO include:

• Shares Offered: 10,000,000
• Price Range: $14.00 to $16.00 per share
• Proposed Exchange: Nasdaq
• Ticker Symbol: APMD

Ad

Potential Proceeds

Based on the proposed price range, Apnimed could raise between $140 million and $160 million in gross proceeds. At the midpoint price of $15.00 per share, the offering would generate $150 million before accounting for underwriting discounts and other offering expenses.

For investors, this IPO represents an opportunity to invest in a new public company. The capital raised is typically used by firms to fund operations, research and development, expansion, or to pay down debt. The final pricing and number of shares sold may differ from the initial filing.